Galcanezumab for prevention of episodic and chronic migraine in real life in Colombia and Mexico: a multicenter prospective cohort study

被引：0
|
作者：
Munoz-Ceron, J. [1 ,2 ]
Velez, K. [3 ]
Rodriguez, I. [3 ]
Hernandez, N. [4 ]
Guerra, C. [4 ,5 ]
Bohorquez, S. [6 ]
Jimenez, J. D. [7 ]
Moreno, C. [2 ,8 ]
Ramos, M. [9 ]
Cavanzo, P. [9 ]
Rojas, Y. [10 ]
Bernal, R. [10 ]
Lopez, R. [11 ]
Gallo, L. [1 ]
机构：
[1] Hosp Univ Mayor Mederi CIMED, Neurol, Bogota, Colombia
[2] Clin Univ Colombia Keralty, Bogota, Colombia
[3] Asociac Mexicana Cefaleas & MIgrana AC, Mexico City, DF, Mexico
[4] SURA, Medellin, Colombia
[5] Clin SOMA, Medellin, Colombia
[6] Hosp Kennedy, Bogota, Colombia
[7] ACN, Pereira, Colombia
[8] ACN, Bogota, Colombia
[9] ACN, Neurol, Bogota, Colombia
[10] ACN, Manizales, Colombia
[11] ACN, Medellin, Colombia
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P255
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Long term (1-year) effectiveness, safety and tolerability of fremanezumab in migraine: a real-life, prospective, cohort, multicenter study
    Egeo, Gabriella
    Aurilia, Cinzia
    Orlando, Bianca
    Fiorentini, Giulia
    D'Onofrio, Florindo
    Albanese, Maria
    Messina, Roberta
    Di Fiore, Paola
    Zucco, Maurizio
    Filippi, Massimo
    Bartolini, Marco
    Bono, Francesco
    Grazzi, Licia
    Querzani, Pietro
    Borrello, Laura
    Doretti, Alberto
    Gai, Annalisa
    Proietti, Stefania
    Bonassi, Stefano
    Vernieri, Fabrizio
    Torelli, Paola
    Barbanti, Piero
    CEPHALALGIA, 2023, 43 (1supp) : 257 - 258
  • [42] Real life experience of one year treatment with galcanezumab in chronic migraine with and without medication overuse headache
    Vaghi, G.
    Bitetto, V.
    De Icco, R.
    Guaschino, E.
    Allena, M.
    Tassorelli, C.
    Sances, G.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 109 - 109
  • [43] Real life experience of one year treatment with galcanezumab in chronic migraine with and without medication overuse headache
    Vaghi, G.
    Bitetto, V.
    De Icco, R.
    Guaschino, E.
    Allena, M.
    Tassorelli, C.
    Sances, G.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 162 - 163
  • [44] Real life experience of one year treatment with Galcanezumab in chronic migraine with and without medication overuse headache
    Vaghi, Gloria
    Bitetto, Vito
    De Icco, Roberto
    Guaschino, Elena
    Allena, Marta
    Tassorelli, Cristina
    Sances, Grazia
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 212 - 213
  • [45] OnabotulinumtoxinA for chronic migraine: a real-life Italian multicenter experience
    Fabrizio Vernieri
    Matteo Paolucci
    Claudia Altamura
    Patrizio Pasqualetti
    Vincenzo Mastrangelo
    Giulia Pierangeli
    Sabina Cevoli
    Domenico D’Amico
    Licia Grazzi
    Neurological Sciences, 2018, 39 : 171 - 172
  • [46] OnabotulinumtoxinA for chronic migraine: a real-life Italian multicenter experience
    Vernieri, Fabrizio
    Paolucci, Matteo
    Altamura, Claudia
    Pasqualetti, Patrizio
    Mastrangelo, Vincenzo
    Pierangeli, Giulia
    Cevoli, Sabina
    D'Amico, Domenico
    Grazzi, Licia
    NEUROLOGICAL SCIENCES, 2018, 39 : S171 - S172
  • [47] Headache Impact of Chronic and Episodic Migraine: Results From the American Migraine Prevalence and Prevention Study
    Buse, Dawn
    Manack, Aubrey
    Serrano, Daniel
    Reed, Michael
    Varon, Sepideh
    Turkel, Catherine
    Lipton, Richard
    HEADACHE, 2012, 52 (01): : 3 - 17
  • [48] SHIFT FROM CHRONIC TO EPISODIC MIGRAINE STATUS AND HIGH- TO LOW-FREQUENCY EPISODIC MIGRAINE STATUS AMONG PATIENTS WITH TREATMENT-RESISTANT MIGRAINE IN A PHASE 3 GALCANEZUMAB STUDY
    Day, Kathleen A.
    Rettiganti, Mallik
    Ferguson, Margaret B.
    Stroud, Chad E.
    Trewin, Benjamin P.
    Takeshima, Takao
    Kingston, William S.
    CEPHALALGIA, 2020, 40 : 75 - 75
  • [49] Efficacy and safety of Fremanezumab in patients with episodic and chronic migraine in a real-life setting
    Gonzalez-Martinez, A.
    Garcia De la Cruz, R.
    Quintas, S.
    Belascoain Gomez, R.
    Heredia, P.
    Vivancos, J.
    Gago-Veiga, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 737 - 737
  • [50] Medication Overuse in a Post-hoc Analysis of Phase 3 Placebo-controlled Studies of Galcanezumab in the Prevention of Episodic and Chronic Migraine
    Aurora, S. K.
    Ruff, D.
    Pearlman, E. M.
    HEADACHE, 2019, 59 : 23 - 23
12345